Siddhant Madhav Joshi is an Investment Analyst at Value Research and a CFA Level II candidate with expertise in mutual fund analysis, portfolio strategy, and personal finance research. Previously with Nuvama Wealth, he brings hands-on experience in wealth management and quantitative evaluation. His articles for Value Research Online and Mutual Fund Insight translate complex market insights into clear, actionable guidance for investors.
By Siddhant Madhav Joshi•4 min read
By Siddhant Madhav Joshi•3 min read
By Siddhant Madhav Joshi•5 min read
By Siddhant Madhav Joshi•4 min read
2 min read•By Value Research
4 min read•By Dhirendra Kumar
By Siddhant Madhav Joshi•3 min read
By Siddhant Madhav Joshi•10 min read
By Siddhant Madhav Joshi•4 min read
4 min read•By Siddhant Madhav Joshi
6 min read•By Siddhant Madhav Joshi
4 min read•By Siddhant Madhav Joshi
| Name | Price Band (Rs) | Bidding Date |
|---|---|---|
| Goldline Pharmaceutical | 41 - 43 | 12-May-2026 to 14-May-2026 |
| RFBL Flexi Pack | 47 - 50 | 12-May-2026 to 14-May-2026 |
| Simca Advertising | 174 - 183 | 08-May-2026 to 12-May-2026 |
| Recode Studios | 150 - 158 | 05-May-2026 to 07-May-2026 |
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
